Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis. - Wikidata - wikimedia - TriplyDB

Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis.

Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis.

http://www.wikidata.org/entity/Q34666702

about

Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury Pericytes are required for blood-brain barrier integrity during embryogenesis Development, maintenance and disruption of the blood-brain barrier How do immune cells support and shape the brain in health, disease, and aging?Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control Focused ultrasound-mediated drug delivery through the blood-brain barrier.Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner.Development and Function of the Blood-Brain Barrier in the Context of Metabolic Control.Central angiotensin II stimulation promotes β amyloid production in Sprague Dawley rats.Protection after stroke: cellular effectors of neurovascular unit integrity.Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.The blood-brain barrier in health and disease.Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.Dissecting gene expression at the blood-brain barrier Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation The blood-brain barrier.Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats.CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes Engaging neuroscience to advance translational research in brain barrier biology.Netrin 1 regulates blood-brain barrier function and neuroinflammation.Effect of systemic infection induced by Pseudomonas aeruginosa on the brain uptake of colistin in mice.Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.Distribution of angiotensin type 1a receptor-containing cells in the brains of bacterial artificial chromosome transgenic mice.Opposing tissue-specific roles of angiotensin in the pathogenesis of obesity, and implications for obesity-related hypertension Decreased spinal cord opioid receptor mRNA expression and antinociception in a Theiler's murine encephalomyelitis virus model of multiple sclerosis.Surgery-Induced Hippocampal Angiotensin II Elevation Causes Blood-Brain Barrier Disruption via MMP/TIMP in Aged Rats.Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease.Genetic mouse models to study blood-brain barrier development and function A lipid-protein hybrid model for tight junction.Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis Methamphetamine-induced occludin endocytosis is mediated by the Arp2/3 complex-regulated actin rearrangement Perivascular spaces and the two steps to neuroinflammation.A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources.The lack of association between angiotensin-converting enzyme gene insertion/deletion polymorphism and nicotine dependence in multiple sclerosis.Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats.Translation in astrocyte distal processes sets molecular heterogeneity at the gliovascular interface.Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin.How do immune cells overcome the blood-brain barrier in multiple sclerosis?Innate immune responses in central nervous system inflammation.Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases.

P2860

Q21245237-A6DF42F7-A9AD-4C0D-981E-D80B844BB2E5 Q24627396-220147F4-BC5C-4BE8-829A-ADCF67E73BBA Q26829668-BF13B4EF-645D-4BBB-9114-1293A53ED522 Q26995364-1EEA32EB-E551-49D2-84E7-DB60DFE4535A Q28081615-4864A068-D702-43EF-BC37-0160A1D67263 Q30394357-15085738-8313-4398-826B-85F9F046CA79 Q33553749-59A85CC5-EA6F-486E-8A1F-45D0B353F60A Q33586092-4648B342-347C-4C58-BBA2-A010F6C32CE3 Q33813065-9801373A-77E5-4A25-AF69-502A217008C4 Q34043168-5B1483E1-620A-4234-8EDD-E1A228DC3FC6 Q34109028-6047FA78-53C0-4ACB-B991-22122231781C Q34320420-1899D162-6035-438A-B414-94281F827348 Q34390088-14F068A7-E15D-4541-B034-68A40E26414E Q34462541-D51B87AB-7A6A-4C3C-A937-EAB8F8FB2349 Q34683399-14FBCBA8-CE64-4803-BDE4-176829E65B07 Q34931170-5B16CCDC-0901-4418-86E5-2D8874AE3CE9 Q34994537-DE2D8873-541C-49E5-9289-613ECF13F022 Q35571261-B3854BE4-2E1F-439C-8DF0-75CF4372C3BB Q35909313-26513C8D-03DE-4BE3-B3D7-21962D8C8501 Q36186795-414DCD56-B3DE-4778-BCD1-5BCB1A4672CC Q36276961-2302E535-A27E-493E-89DA-2F76149F7D48 Q36410269-9D6F2372-A8D1-4566-B841-7147840B6607 Q36422011-DD2819F2-E781-425A-A566-7C23D73A675F Q36422534-625DCF21-5E05-4335-A90E-8BCB8E7FA2E3 Q36482109-7FA25D1C-2876-4E62-8251-F3038346A871 Q36834432-3E538931-E434-42FD-8F54-141EA9DBEF28 Q36901428-A93FFA80-780D-49D4-B2F9-92F82F91BC8A Q36909576-79B801FA-A303-491C-A1C9-6B9AF0BCC3BC Q37018423-7BA7CA22-6178-4714-B6CC-EF46471BE648 Q37194323-0AC79EFB-558B-4509-BD01-DA901A7EF3DF Q37311433-3C662635-A97A-4582-B25A-DEA0C7EB28E4 Q37329042-D2C5C621-9529-4F03-8EFD-1372ED218878 Q37598924-0594D83A-804A-4E8F-A3CD-F7D7F1D19143 Q37599662-9F230475-1A3B-4CCB-A943-295B4DD0CDC6 Q37671307-505C537B-8E4C-40EA-AE5C-B5CC942AC7CA Q37724151-6815C633-47A9-4686-93F3-23652F5DDDDD Q37813804-A4733289-5BBF-4FA8-87B2-CE30C1623646 Q37873072-FC87B678-EA3E-4AEF-8AE5-07A5074CEC83 Q37882071-8578C76D-D982-47F8-AD3F-56BC77CC547D Q38021079-21A718F1-A526-4FF3-99F4-29070F0EE8AF

P2860

Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis.

http://www.wikidata.org/entity/Q34666702

description

2007 nî lūn-bûn

@nan

2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Angiotensin II controls occlud ...... levance to multiple sclerosis.

@ast

Angiotensin II controls occlud ...... levance to multiple sclerosis.

@en

Angiotensin II controls occlud ...... levance to multiple sclerosis.

@nl

type

label

Angiotensin II controls occlud ...... levance to multiple sclerosis.

@ast

Angiotensin II controls occlud ...... levance to multiple sclerosis.

@en

Angiotensin II controls occlud ...... levance to multiple sclerosis.

@nl

prefLabel

Angiotensin II controls occlud ...... levance to multiple sclerosis.

@ast

Angiotensin II controls occlud ...... levance to multiple sclerosis.

@en

Angiotensin II controls occlud ...... levance to multiple sclerosis.

@nl

P1433

Q34666702-E4E42317-C9A4-4DC9-856D-79105B2114EE

P1476

Q34666702-6AFC11E8-78E0-493C-8C1C-144BCE0AD3F0

P2093

Q34666702-13C3EBB9-1092-44FF-9342-1BDBF91F4619

Q34666702-3068CE3F-D4FC-4723-ACA4-0A3FF49586B9

Q34666702-5D01D768-9743-4624-9EB7-7AC8598B37D0

Q34666702-8B145544-DDF4-4DA9-8155-E14ABDBDA3E3

Q34666702-94A510F5-64DB-4390-856D-82F4FCC14475

Q34666702-D385643B-71D0-471B-A4C0-074D469DCFCA

Q34666702-F3FB5812-DEEC-4FDF-948E-75D3F048A9A6

Q34666702-FA1977D9-961F-4154-8D0E-DD4ADFC0A8EB

P304

Q34666702-37B0E297-D534-47BE-A49B-301E08E767E5

P31

Q34666702-8FD6A874-D732-4D53-90B5-C14E7E6F1FB6

P356

Q34666702-1E6FAEDF-70FA-4054-9989-82374803DC36

P407

Q34666702-5E580DBE-B4DA-4ADF-A84C-B3304D55EA7F

P433

Q34666702-1F087CA9-D87F-4166-8412-D67EC92005DA

P478

Q34666702-1EA3F457-C27F-4991-94C3-DA9352E0560D

P50

Q34666702-457124A6-A57B-47F1-913B-DCD80E6D39C8

P577

Q34666702-0E61939B-2646-42ED-A4D6-AE674E1FAF12

P698

Q34666702-E9580B44-60B9-4919-8BE8-C582337B3BC0

P921

Q34666702-58FAF4B0-17A6-44DB-87DB-4A8D4AA9318A

Q34666702-A8832189-1DFD-4C51-8CB4-C0C1685CC9A5

P932

Q34666702-AD148A49-4DED-43EA-97AD-CE26699AA923

P356

JNEUROSCI.2088-07.2007

P1433

Journal of Neuroscience

P1476

Angiotensin II controls occlud ...... levance to multiple sclerosis.

@en

P2093

Alain Bouthillier

http://www.w3.org/2001/XMLSchema#string

Aurore Dodelet-Devillers

http://www.w3.org/2001/XMLSchema#string

France Berthelet

http://www.w3.org/2001/XMLSchema#string

Karolina Wosik

http://www.w3.org/2001/XMLSchema#string

Monique Bernard

http://www.w3.org/2001/XMLSchema#string

Robert Moumdjian

http://www.w3.org/2001/XMLSchema#string

Romain Cayrol

http://www.w3.org/2001/XMLSchema#string

Timothy L Reudelhuber

http://www.w3.org/2001/XMLSchema#string

P304

9032-9042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1523/JNEUROSCI.2088-07.2007

http://www.w3.org/2001/XMLSchema#string

P407

P433

34

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17715340

http://www.w3.org/2001/XMLSchema#string

P921

blood–brain barrier

multiple sclerosis

P932

6672193

http://www.w3.org/2001/XMLSchema#string